← Back to Search

Contact Lenses

Control/Test for Ocular Physiology

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 39 (inclusive) years of age at the time of screening.
In both eyes, have refractive error suitable for correction with the toric contact lens powers available in this study:
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 2 weeks of contact lens wear for each study lens
Awards & highlights

Study Summary

This trial will compare different eye treatments to test which is most effective for improving eye health.

Who is the study for?
This trial is for people aged 18-39 who currently wear soft contact lenses and have good vision with correction. They must be able to follow the study's instructions, not be pregnant or breastfeeding, diabetic, or have any eye diseases or conditions that affect lens wear.Check my eligibility
What is being tested?
The study compares two types of daily disposable toric soft contact lenses: Senofilcon A (test) and Delefilcon A (control). Participants will try both in a random order to see how their eyes respond over two weeks.See study design
What are the potential side effects?
While specific side effects are not listed, wearing contact lenses can sometimes cause dryness, discomfort, redness, blurry vision, and in rare cases infections if hygiene guidelines aren't followed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 39 years old.
Select...
My eyesight can be corrected with the contact lenses available in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 2 weeks of contact lens wear for each study lens
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 2 weeks of contact lens wear for each study lens for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Slit Lamp Examination Findings (SLF)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Test/ControlExperimental Treatment2 Interventions
Eligible subjects who are habitual soft contact lens wearers will be randomized into the Test/Control sequence, to wear two different study lenses, one at a time, over two wear periods (test then control). Each wear period will be approximately 2 weeks in duration, with a washout period of approximately 1 week between wear periods. Subjects will be advised to wear the study lenses for a minimum of 8 hours per day on at least 5 days per week of each wear period.
Group II: Control/TestExperimental Treatment2 Interventions
Eligible subjects who are habitual soft contact lens wearers will be randomized into the Control/Test sequence, to wear two different study lenses, one at a time, over two wear periods (control then test). Each wear period will be approximately 2 weeks in duration, with a washout period of approximately 1 week between wear periods. Subjects will be advised to wear the study lenses for a minimum of 8 hours per day on at least 5 days per week of each wear period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Senofilcon A contact lenses (TEST)
2023
N/A
~70
Delefilcon A contact lenses (CONTROL)
2023
N/A
~70

Find a Location

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor
216 Previous Clinical Trials
25,494 Total Patients Enrolled
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
44 Previous Clinical Trials
4,368 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are enrolled in the current investigation?

"Johnson & Johnson Vision Care, Inc. is responsible for the trial's facilitation which requires 66 compliant patients from two sites: Omega Vision Center in Longwood, Ohio and ProCare Vision Centers in Granville, Texas."

Answered by AI

Is this research endeavor currently accepting new participants?

"Affirmative. According to clinicaltrials.gov, the trial is currently in search of participants and was first posted on November 16th 2023 before being updated most recently on December 6th 2023. The study requires 66 patients from 6 distinct sites."

Answered by AI

Are there numerous facilities conducting this clinical investigation in the state?

"This research study is being conducted by 6 different vision care centers, including Omega Vision Center in Longwood, ProCare Vision Centers in Granville and Professional Vision Care Inc. - Westerville in Westerille."

Answered by AI

Does the candidacy for this clinical trial extend beyond individuals under and up to 35 years of age?

"Eligible participants for this experiment are adults aged 18 to 39 years."

Answered by AI

Are there any limitations to joining this research program?

"The requirements to join this clinical trial are the possession of ocular physiology and being aged between 18-39. As of now, approximately 66 participants have been admitted into the study."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear
2023. "Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06161012.
All > Tampa
~45 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top